COVID-19 Vaccines and Kids: Lessons Learned and Remaining Challenges

COVID-19 Vaccines and Kids: Lessons Learned and Remaining Challenges

Recorded On: 03/23/2022

  • Register
    • Non-Member - Free!
    • 5 Year Doctoral Level Member - Free!
    • 5 Year Non-Doctoral Level Member - Free!
    • Doctoral Level Members - Free!
    • Associate Doctoral Level Members - Free!
    • Retiree Doctoral Level Members - Free!
    • Non-Doctoral Level Members - Free!
    • Lifetime Retiree Doctoral Level Member - Free!
    • Associate Non-Doctoral Level Members - Free!
    • Retiree Non-Doctoral Level Members - Free!
    • Lifetime Retiree Non-Doctoral Level Member - Free!
    • Limited (Student/Trainee) Level Members - Free!
    • Special Associate Member - Free!
    • Staff/Administration - Free!
    • Hon. Lifetime Member - Free!

Title:   COVID-19 Vaccines and Kids: Lessons Learned and Remaining Challenges 

Date:   23 March 2022

Time:  16.00 EDT UTC-04 (4:00 PM EDT UTC-04)

To check your time zone, go to the time and date website: Here

Webinar Support

ISTM would like to extend a special thank you to Sanofi Pasteur for their generous support with an unrestricted educational grant!


Webinar Program Planning Information

This webinar is brought to you by the ISTM Professional Education Committee (PEC) in collaboration with the ISTM Pediatric Interest Group.

Chair: Sarah Kohl, United States

Co-Chair: Yen-Giang Bui, Canada

Immediate Past President ISTM: Lin Chen, United States

PEDS Chair: Sheila Mackell, United States

Moderator: John C. Christenson, United States


Elizabeth Barnett, United States

Margie Danchin, Australia

Leah D. Kern, United States


Even though children and adolescents may be less physically affected by COVID-19, their lives have suffered enormous disruptions through school closures and socially distancing measures. The Omicron variant with its higher transmissibility has caused an important increase in the total number of cases of COVID-19 in younger age groups. The full impact of late complications such as MIS-C, long COVID, plus the effects of social isolation, lack of stimulation on kids’ development will linger on long after this pandemic is over. Effective and safe vaccines against COVID-19 have been available since last fall, but vaccine hesitancy in parents and questions around rare side effects such as myocarditis have hindered vaccinal uptake.

Our experts will share with you the latest epidemiological data on the burden of this pandemic in children and adolescents, and review vaccines’ effectiveness and safety in these age groups. They will also review strategies to overcome vaccine hesitancy and optimize vaccination coverage.

Course Objectives:

By the end of this webinar, the attendee should be able to:

  • Review the latest epidemiological data on COVID-19 in children and adolescents, including MIS-C
  • Recognize the psychosocial burden of the pandemic on children and adolescents 
  • Discuss the effectiveness and safety of COVID-19 vaccines in children and adolescents
  • Explore the reasons for vaccine hesitancy in parents and use effective communication strategies to overcome them

Who Should Attend:

  • Infectious Disease Practitioners – Doctors, Nurses, and Pharmacists
  • Travel Health Practitioners – Doctors, Nurses, and Pharmacists
  • Public Health Practitioners
  • Family Medicine Practitioners
  • Paediatricians
  • Any others who care for travelers and children

The webinar is complimentary to members and non-members, but you still must register to attend. The webinar Zoom link will be sent to you in your registration confirmation email.

Elizabeth Barnett, MD

Professor of Pediatrics

Boston University School of Medicine, USA

Elizabeth Barnett is a pediatrician with a specialty in infectious diseases working in an urban hospital with a large international population.  Her career focus has been in general pediatric infectious diseases, travel and topical medicine, immigrant medicine, vaccines and vaccine safety, and antimicrobial therapy and resistance.  With colleagues in the adult infectious diseases group, she founded the Travel Clinic at Boston Medical Center in the early 1990s and the Refugee Health Assessment Program a few years later.  Her research interests have included travel medicine – through the Boston Area Travel Medicine Network (BATMN), a collaboration of 5 travel clinics in the Greater Boston Area – immigrant medicine, and vaccines, including participation in clinical trials of Japanese Encephalitis vaccine in children and oral cholera vaccine.  Dr. Barnett has been Site Director for the Boston GeoSentinel site since the 1990s, contributing over 6000 records.  Current academic and administrative activities include being the Pediatric Infectious Diseases Fellowship Program Director, a member of the BUSM Promotions Committee, and a member of the Leadership Group of GeoSentinel.  Dr. Barnett has also been active in ISTM for over 20 years, including participation in the Migrant Interest Group, and Director/Co-Director of the ISTM Review Course.

John C. Christenson, MD, FAAP, FIDSA, FPIDS (Moderator)

Professor of Clinical Pediatrics at the Indiana University School of Medicine

Director of the Pediatric Travel Medicine Clinic at Riley Hospital for Children, USA

Dr. John C. Christenson is a Professor of Clinical Pediatrics at the Indiana University School of Medicine and Director of the Pediatric Travel Medicine Clinic at Riley Hospital for Children. He completed his medical studies and pediatric residency at the University of Puerto Rico in San Juan, Puerto Rico, followed by a fellowship in pediatric infectious diseases at the University of Oklahoma Health Sciences Center. Dr. Christenson is board-certified in pediatric infectious diseases, and has a Certificate of Knowledge in Clinical Tropical Medicine and Travelers’ Health from the American Society of Tropical Medicine and Hygiene, and a Certificate of Knowledge in Travel Health from the International Society of Travel Medicine. He is a Fellow of the American Academy of Pediatrics, the Infectious Diseases Society of America, and the Pediatric Infectious Diseases Society. Dr. Christenson has for many years been involved in international educational and health projects in Guatemala, Central America. His clinical interests are medical education, infection prevention, travel and geographic medicine, clinical infectious diseases, histoplasmosis, and immunizations. 

Margie Danchin, MBBS, PhD, FRACP

A/Prof and Clinician Scientist Fellow

Murdoch Children's Research Institute and The University of Melbourne in Melbourne, Australia

A/Prof Margie is consultant paediatrician within the Department of Paediatrics, University of Melbourne and Murdoch Childrens Research Institute (MCRI). She is Group Leader, Vaccine acceptance, Uptake and Policy, at MCRI, and is an immunisation expert with over ten years of experience in vaccine research and clinical work, both in Australia and in resource poor settings. She has expertise in vaccine clinical trials, vaccine safety, program evaluation, health system strengthening and implementation research in low resource settings, social science and vaccine policy. Her research program is focused on improving vaccine confidence, demand and uptake of licensed vaccines in different settings and populations.

This is achieved by developing, trialing and translating effective, multi-component interventions in pregnancy and early childhood, in at risk populations and in low resource settings. She is also developing a new tool to enable diagnosis of the causes of under-vaccination in different populations to ensure cost-effective, targeted interventions to improve vaccine uptake in children under 5 years. She is at the forefront of understanding vaccine confidence nationally and internationally and has strong collaborations with leaders in the field.

She is the current chair of the Collaboration on Social Science in Immunisation (COSSI) Group, an initiative of the National Centre for Immunisation Research and Surveillance (NCIRS), a member of Sabin's Vaccine and Acceptance Research Network (VARN) steering group and is engaged as a WHO consultant to address the rise in measles cases and vaccine confidence issues in the Philippines.

Leah D. Kern, MD, MPH

Associate Clinical Professor of Pediatrics

Division of Academic General Pediatrics, University of California, San Diego, USA

As an Associate Clinical Professor of Academic General Pediatrics, I focus my career on providing direct clinical care to patients and on educating medical students and residents with a concentration on pediatric HIV care, pediatric travel medicine and general pediatrics. 

From 2006-2008, I worked for the Baylor International Pediatric AIDS Initiative in Burkina Faso and provided direct medical care to several hundred HIV-exposed and HIV-infected children.  From 2009 until 2014, I served as advisor to the prevention of mother-to-child transmission (PMTCT) and pediatric HIV components of UCSD's Program for PEPFAR Support to the Uniformed Services of Ethiopia (USE). Since 2015, I have worked as a pediatrician for the UCSD Mother, Child, and Adolescent HIV Program. I provide direct patient care for HIV-exposed infants and for HIV infected children and adolescents. I also focus on educating UCSD medical students and residents about the care of HIV-exposed infants and HIV-infected children.

At UCSD Academic General Pediatrics, I provide general pediatrics care and am the Director of the Pediatric Travel Clinic. I provide pre- and post-travel consults for children traveling internationally. Currently, I am the principal investigator of a research project to examine the pre-travel health preparation of children and young adults by general pediatricians compared with the travel medicine clinic.

My other research interests focus on the implementation of the American Academy of Pediatrics’ universal screening recommendations the in General Pediatrics clinic. Over the past several years, I have conducted research related to universal cholesterol screening in children and post-partum depression screening in infants’ mothers. Recently, I completed research to evaluate the long-term impact of universal lipid screening and the physician management of those with dyslipidemia among children aged 9-11 years old. Currently, I am the principal investigator on a project to examine the long-term impact and follow-up of the mother-infant dyad of mothers screening positive for post-partum depression.

I plan to continue to focus my research on improving the quality of care for children in the general pediatrics clinic, the pediatrics travel clinic and the HIV clinic.

You must be logged in to post to the discussion


On-demand recording of the live webinar
Open to view video.
Open to view video. On-demand recording of the live webinar
Webinar Survey: COVID-19 Vaccines and Kids: Lessons Learned and Remaining Challenges
15 Questions
15 Questions Webinar Survey: COVID-19 Vaccines and Kids: Lessons Learned and Remaining Challenges
CPD Certificate
Live Viewing: 1.50 CPD credits and certificate available
Live Viewing: 1.50 CPD credits and certificate available CPD Certificate
Efficacy and Safety of COVID Vaccines in Children - Elizabeth Barnett
Open to download resource.
Open to download resource. PowerPoint Presentation
730+ Days of the COVID-19 Pandemic:Update on Children and Adolescents - Leah Kern
Open to download resource.
Open to download resource. PowerPoint Presentation
Vaccine Hesitancy - Margie Danchin
Open to download resource.
Open to download resource. PowerPoint Presentation